Aggrey Semeere

980 total citations
46 papers, 559 citations indexed

About

Aggrey Semeere is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Aggrey Semeere has authored 46 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 18 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Aggrey Semeere's work include HIV/AIDS Research and Interventions (19 papers), Viral-associated cancers and disorders (17 papers) and Lymphoma Diagnosis and Treatment (10 papers). Aggrey Semeere is often cited by papers focused on HIV/AIDS Research and Interventions (19 papers), Viral-associated cancers and disorders (17 papers) and Lymphoma Diagnosis and Treatment (10 papers). Aggrey Semeere collaborates with scholars based in Uganda, United States and Kenya. Aggrey Semeere's co-authors include Jeffrey N. Martin, Naftali Busakhala, Toby Maurer, Andrew Kambugu, Barbara Castelnuovo, Joseph B. Sempa, Esther E. Freeman, Yukari C. Manabe, Brandon J. Auerbach and David Erickson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Aggrey Semeere

43 papers receiving 552 citations

Peers

Countries citing papers authored by Aggrey Semeere

Since Specialization

Citations

This map shows the geographic impact of Aggrey Semeere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aggrey Semeere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aggrey Semeere more than expected).

Fields of papers citing papers by Aggrey Semeere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aggrey Semeere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aggrey Semeere. The network helps show where Aggrey Semeere may publish in the future.

Co-authorship network of co-authors of Aggrey Semeere

This figure shows the co-authorship network connecting the top 25 collaborators of Aggrey Semeere. A scholar is included among the top collaborators of Aggrey Semeere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aggrey Semeere. Aggrey Semeere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Data validation in multinational observational studies with error-prone data: applying an optimal validation sampling strategy in a study of Kaposi sarcoma and HIV 2025 ·American Journal of Epidemiology ·(unknown), Jeremy S. Slone, Aggrey Semeere, Lameck Diero, Larissa Otero, Brenda Crabtree‐Ramírez, Ran Tao, Stephany N. Duda, Beverly Musick, (unknown), Thomas Lumley, Pamela A. Shaw, Bryan E. Shepherd	0
2	Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries 2025 ·JCO Global Oncology ·(unknown), (unknown), (unknown), Rebecca Richards‐Kortum, Sally M. McFall, Robert L. Murphy, Aggrey Semeere, David Erickson	2
3	Acceptability of short message service reminders as the support tool for PrEP adherence among young women in Mukono district, Uganda 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Sabrina Bakeera–Kitaka, Fred C. Semitala, Aggrey Semeere, Charles Karamagi	1
4	Survival and predictors of mortality after completion of TB treatment among people living with HIV: a 5-year analytical cohort 2023 ·BMC Infectious Diseases ·(unknown), Joseph Musaazi, Aggrey Semeere, Ian Handel, Barbara Castelnuovo	3
5	Telling the story of intersectional stigma in HIV‐associated Kaposi's sarcoma in western Kenya: a convergent mixed‐methods approach 2022 ·Journal of the International AIDS Society ·(unknown), (unknown), Aggrey Semeere, Helen Byakwaga, (unknown), Devon E. McMahon, (unknown), Merridy Grant, Lisa Butler, Laura M. Bogart, Ingrid V. Bassett, (unknown), Toby Maurer, Jeffrey N. Martin, (unknown), Esther E. Freeman	9
6	Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: a qualitative study 2022 ·Infectious Agents and Cancer ·Devon E. McMahon, (unknown), (unknown), Aggrey Semeere, Helen Byakwaga, Merridy Grant, (unknown), (unknown), (unknown), Toby Maurer, Jeffrey N. Martin, Ingrid V. Bassett, Lisa Butler, (unknown), Naftali Busakhala, Esther E. Freeman	4
7	A type III effectiveness-implementation hybrid evaluation of a multicomponent patient navigation strategy for advanced-stage Kaposi’s sarcoma: protocol 2022 ·SHILAP Revista de lepidopterología ·(unknown), Aggrey Semeere, Helen Byakwaga, (unknown), (unknown), Anjuli D. Wagner, Ingrid V. Bassett, Kara Wools‐Kaloustian, Toby Maurer, Jeffrey N. Martin, (unknown), Esther E. Freeman	5
8	Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis 2022 ·The Lancet Global Health ·Esther E. Freeman, Nicole C. McCann, Aggrey Semeere, Krishna P. Reddy, (unknown), Helen Byakwaga, (unknown), (unknown), (unknown), Naftali Busakhala, Jeffery N Martin, Toby Maurer, Ingrid V. Bassett, Kenneth A. Freedberg, Emily P. Hyle	4
9	Implementing screening for hypertension in archetypal HIV primary care: a mixed-methods assessment 2022 ·BMC Health Services Research ·(unknown), (unknown), (unknown), (unknown), Anne Katahoire, Elvin Geng, Aggrey Semeere	6
10	Beyond T Staging in the “Treat-All” Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa 2021 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Esther E. Freeman, Aggrey Semeere, Devon E. McMahon, Helen Byakwaga, (unknown), Susan Regan, Megan Wenger, (unknown), (unknown), Mwebesa Bwana, (unknown), (unknown), (unknown), (unknown), Kara Wools‐Kaloustian, Ingrid V. Bassett, Naftali Busakhala, Jeffrey N. Martin	11
11	A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda 2019 ·BMJ Open ·(unknown), Noeline Nakasujja, Linnet Ongeri, Aggrey Semeere, Rachel Loewy, Susan M. Meffert	4
12	Smartphone confocal microscopy for imaging cellular structures in human skin in vivo 2018 ·Biomedical Optics Express ·Esther E. Freeman, Aggrey Semeere, Hany Osman, Gary Peterson, Milind Rajadhyaksha, Salvador González, Jeffery N Martin, R. Rox Anderson, Guillermo J. Tearney, Dongkyun Kang	43
13	Global health leadership training in resource-limited settings: a collaborative approach by academic institutions and local health care programs in Uganda 2015 ·Human Resources for Health ·Damalie Nakanjako, Elizabeth Namagala, Aggrey Semeere, (unknown), Joseph B. Sempa, (unknown), Achilles Katamba, Sam Biraro, Sarah Naikoba, Yohana Mashalla, Carey Farquhar, Nelson K. Sewankambo	32
14	Implementation and Operational Research 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Mara E. Murray Horwitz, (unknown), Brandon J. Auerbach, Aggrey Semeere, (unknown), (unknown), (unknown), Allan Muruta, David B. Meya, Yukari C. Manabe	20
15	Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem 2015 ·Oncology ·(unknown), Megan Wenger, Aggrey Semeere, Barbara Castelnuovo, Andrew Kambugu, Robert Lukande, Fredrick Chite Asirwa, Naftali Busakhala, Nathan Buziba, Lameck Diero, Kara Wools‐Kaloustian, Robert Matthew Strother, Mwebesa Bwana, Winnie Muyindike, Erin Amerson, Edward Mbidde, Toby Maurer, Jeffrey N. Martin	25
16	Mortality and Immunological Recovery Among Older Adults on Antiretroviral Therapy at a Large Urban HIV Clinic in Kampala, Uganda 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Aggrey Semeere, (unknown), Joseph B. Sempa, (unknown), Noeline Nakasujja, Robert G. Cumming, Andrew Kambugu, Harriet Mayanja‐Kizza	22
17	Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial 2013 ·PLoS ONE ·(unknown), Ekwaro A. Obuku, Sarah Walker, Aggrey Semeere, Brandon J. Auerbach, James Hakim, Harriet Mayanja‐Kizza, Peter Mugyenyi, Robert A. Salata, Cissy Kityo, (unknown)	7
18	Sub-Optimal Vitamin B-12 Levels among ART-Naïve HIV-Positive Individuals in an Urban Cohort in Uganda 2012 ·PLoS ONE ·Aggrey Semeere, Damalie Nakanjako, Henry Ddungu, Andrew Kambugu, Yukari C. Manabe, Robert Colebunders	15
19	Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings 2012 ·Current Opinion in Oncology ·Aggrey Semeere, Naftali Busakhala, Jeffrey N. Martin	40
20	Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda 2012 ·BMC Public Health ·Joseph B. Sempa, (unknown), Andreas Kuznik, Mohammed Lamorde, Stefanie Sowinski, Aggrey Semeere, Sabine Hermans, Barbara Castelnuovo, Yukari C. Manabe	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact